Hypertension: a new treatment for an old disease? Targeting the immune system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypertension: a new treatment for an old disease? Targeting the immune system

Published:2018-07-31 Issue:12 Volume:176 Page:2028-2048
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Bomfim Gisele Facholi¹,Cau Stefany Bruno Assis²^ORCID,Bruno Alexandre Santos²,Fedoce Aline Garcia³,Carneiro Fernando S³^ORCID

Affiliation:

1. Institute of Health SciencesFederal University of Mato Grosso Sinop MT Brazil

2. Department of Pharmacology, Institute of Biological ScienceFederal University of Minas Gerais Belo Horizonte MG Brazil

3. Department of Pharmacology, Ribeirão Preto Medical SchoolUniversity of São Paulo São Paulo Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14436

Reference167 articles.

1. Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]

2. Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients

3. Influence of Angiotensin II on Expression of Toll-like Receptor 2 and Maturation of Dendritic Cells in Chronic Cyclosporine Nephropathy

4. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases;Al‐Bari MA;J Antimicrob Chemother,2015

5. The ACE inhibitors enalapril and captopril modulate cytokine responses in Balb/c and C57Bl/6 normal mice and increase CD4+CD103+CD25negative splenic T cell numbers

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like receptor 4 mutation mitigates gut microbiota-mediated hypertensive kidney injury;Pharmacological Research;2024-08

2. Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension;Ageing Research Reviews;2024-08

3. Standard Doses of Cholecalciferol Reduce Glucose and Increase Glutamine in Obesity-Related Hypertension: Results of a Randomized Trial;International Journal of Molecular Sciences;2024-03-18

4. Immunization, Vaccines, and Immunomodulation;Early Vascular Aging (EVA);2024

5. MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension;Biochemical Pharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3